Canbio Pharmaceuticals LLP

Canbio Pharmaceuticals LLP - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
LLPIN AAS-5978 Incorporated 12 June 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership pharma
Revenue · FY 2024
₹9.1 Cr
▲ 121% YoY
Net profit · FY 2024
₹12.33 Lakh
Net margin 1.4%
EBITDA · FY 2024
₹70.93 Lakh
EBITDA margin 7.8%
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹7.15 Cr
Secured borrowings
LLP age
6 yrs
Est. 2020
Designated partners
8
As per MCA filings
Active GSTINs
1
GST registered

About Canbio Pharmaceuticals LLP

Data last updated:

Canbio Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2020 and has been in existence for over 6 years.

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAS-5978. Its GSTIN is 24AAPFC4083N1ZZ (Gujarat).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Bhupendrabhai Valjibhai Patel and Rabindra Kumar Mohanty.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.

As per the financials filed for FY 2024, the LLP reported a revenue of ₹9.1 Cr, a growth of 121% compared to the previous year. For the same year it recorded a net profit of ₹12.33 Lakh (net margin 1.4%) and EBITDA of ₹70.93 Lakh (EBITDA margin 7.8%).

As per MCA filings, the LLP has open charges of ₹7.15 Cr on record.

Company details

LLPIN AAS-5978
Incorporation Date 12 June 2020
Total Obligation of Contribution ₹1 Lakh
ROC Ahmedabad
Company Status Active

Contact details

Canbio Pharmaceuticals LLP's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Canbio Pharmaceuticals LLP, buy the company report.

Comprehensive company report
Canbio Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Canbio Pharmaceuticals LLP

FY 2025 filings available

Canbio Pharmaceuticals LLP reported revenue of ₹9.1 Cr (up 121% YoY) for FY 2024.

Revenue · FY 2024
₹9.1 Cr ▲ 121%
Net profit · FY 2024
₹12.33 Lakh margin 1.4%
EBITDA · FY 2024
₹70.93 Lakh margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 121%

Revenue rose 121% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income₹9.1 Cr
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹12.33 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin1.4%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Canbio Pharmaceuticals LLP, buy the company report.

Designated partners of Canbio Pharmaceuticals LLP

Canbio Pharmaceuticals has 8 current designated partners and 6 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Bhupendrabhai Valjibhai PatelDesignated Partner12 Jun 20206 Years 5 MonthsCurrent
Rabindra Kumar MohantyDesignated Partner02 Sep 20206 Years 2 MonthsCurrent
Bharatkumar Vitthalbhai PatelDesignated Partner03 Oct 20242 Years 1 MonthsCurrent
Pathik Bharatkumar SheladiaDesignated Partner01 Sep 20224 Years 2 MonthsCurrent
Harsukhbhai Jasmatbhai VekariaDesignated Partner12 Jun 20206 Years 5 MonthsCurrent
Kishorkumar Vrajlal RakholiyaDesignated Partner03 Oct 20242 Years 1 MonthsCurrent
Showing 6 of 8 current designated partners. View all designated partners

Charges & borrowings

Open charges
₹7.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Icici Bank Limited₹4.15 Cr
Bank of Baroda₹3.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Dec 2024101067909Icici Bank Limited₹75 LakhOpen
24 Dec 2024101067905Icici Bank Limited₹3.4 CrOpen
15 Feb 2021100416891Bank of Baroda₹3 CrOpen

To see the full charge records of Canbio Pharmaceuticals LLP, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Canbio Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Canbio Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAPFC4083N1ZZGujaratActive28 Jul 2020

To see the full GST registrations and return filing status of Canbio Pharmaceuticals LLP, buy the company report.

Recent activity

Canbio Pharmaceuticals LLP has 14 designated partner changes on record since 2020: 8 appointments and 6 cessations. The latest: Dwij Kishorbhai Rakholiya was appointed as Designated Partner on 01 Aug 2025.

Appointed
Dwij Kishorbhai Rakholiya was appointed as Designated Partner.
Appointed
Rahul Rajaram Kondekar was appointed as Designated Partner.
Charges
A charge with Icici Bank Limited of Rs. 340.00 Lakh registered on 24 Dec 2024 with Charge ID 101067905 was modified on 23 Jul 2025.
AGM
Canbio Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Canbio Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Icici Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 101067909 was registered on 24 Dec 2024.
Charges
A charge with Icici Bank Limited amounted to Rs. 340.00 Lakh with Charge ID 101067905 was registered on 24 Dec 2024.
Appointed
Bharatkumar Vitthalbhai Patel was appointed as Designated Partner.
Ceased
Bhupendrabhai Valjibhai Patel ceased to be Designated Partner.
Appointed
Kishorkumar Vrajlal Rakholiya was appointed as Designated Partner.
Ceased
Pathik Bharatkumar Sheladia ceased to be Designated Partner.
Ceased
Zankar Vallabhbhai Savalia ceased to be Designated Partner.

9 earlier events are in the company report.

Frequently asked questions

Canbio Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2020 (6+ years old) and is registered under LLPIN AAS-5978.

Canbio Pharmaceuticals has 8 current designated partners:

The latest financial statements of Canbio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Canbio Pharmaceuticals is 24AAPFC4083N1ZZ, registered in Gujarat.

The LLPIN (Limited Liability Partnership Identification Number) of Canbio Pharmaceuticals is AAS-5978. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Canbio Pharmaceuticals was incorporated on 12 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Dwij Kishorbhai Rakholiya was appointed as Designated Partner on 01 Aug 2025. Rahul Rajaram Kondekar was appointed as Designated Partner on 01 Aug 2025. Bharatkumar Vitthalbhai Patel was appointed as Designated Partner on 03 Oct 2024. Canbio Pharmaceuticals has 14 designated partner changes on record in total.

The registered office of Canbio Pharmaceuticals is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.

Canbio Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Canbio Pharmaceuticals has open charges of ₹7.15 Cr and no satisfied charges on record as per latest MCA filings.